Effects of Lomitapide on Carotid and Aortic Atherosclerosis in Patients Treated With Lomitapide in Usual Care (CAPTURE)
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 18 Dec 2017
At a glance
- Drugs Lomitapide (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms CAPTURE
- Sponsors Aegerion Pharmaceuticals
- 13 Dec 2017 Planned primary completion date changed from 1 Apr 2021 to 1 Dec 2018.
- 13 Dec 2017 Planned initiation date changed from 1 Apr 2015 to 1 Jun 2015.
- 13 Dec 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.